Abacavir and Mycophenolic Acid, an Inhibitor of Inosine Monophosphate Dehydrogenase, Have Profound and Synergistic Anti-HIV Activity
- 1 August 1999
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 21 (5), 362
- https://doi.org/10.1097/00042560-199908150-00002
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infectionAIDS, 1998
- Combination of a Drug Targeting the Cell with a Drug Targeting the Virus Controls Human Immunodeficiency Virus Type 1 ResistanceAIDS Research and Human Retroviruses, 1997
- Treatment of Human Immunodeficiency Virus Infection with Hydroxyurea: Virologic and Clinical EvaluationThe Journal of Infectious Diseases, 1996
- Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individualsAntiviral Research, 1996
- Hydroxyurea as an Inhibitor of Human Immunodeficiency Virus-Type 1 ReplicationScience, 1994
- Mechanisms of Action of Mycophenolic AcidAnnals of the New York Academy of Sciences, 1993
- Distinct biological and serological properties of human immunodeficiency viruses from the brainAnnals of Neurology, 1988
- Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitroAntimicrobial Agents and Chemotherapy, 1987
- Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque AssayScience, 1985
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984